苏州创新药研究院揭牌

Core Viewpoint - The establishment of the Suzhou Innovation Drug Research Institute marks a significant step in promoting the biopharmaceutical industry in Suzhou, focusing on innovation and collaboration among government, academia, and enterprises [1][2]. Group 1: Establishment and Purpose - The Suzhou Innovation Drug Research Institute was inaugurated on September 29, with key figures from the government and academia in attendance [1]. - The institute aims to serve as a "catalyst" for technological breakthroughs, a "nurturer" for top talent, and a "connector" for the transformation of research outcomes, thereby becoming a source of innovation for Suzhou's biopharmaceutical industry [1]. Group 2: Collaborative Framework - The institute is a collaborative effort between the Suzhou municipal government, Suzhou Industrial Park, and Suzhou University, adhering to the principle of "enterprises pose questions, jointly solve problems, and the government assists" [2]. - It will focus on cutting-edge fields such as molecular targeted drugs, biopharmaceuticals, gene and cell therapy, and AI drug development, aiming to create an organized research and transformation framework [2]. Group 3: Integration and Development - The research institute seeks to establish a three-in-one innovation loop involving laboratories, enterprises, and hospitals, promoting deep integration of government, industry, academia, research, and medical sectors [2]. - During the inauguration, the institute also unveiled joint innovation centers with Ascentage Pharma and Innovent Biologics, and held its first council meeting [2].